Loading clinical trials...
Loading clinical trials...
The Issue of Late Recourse to HIV Testing. A Study of the Psychosocial Factors at Play Within Men Who Have Sex With Men in France.
The present study will try to investigate and analyze the psycho-social hindrances and levers concerning the recourse to late HIV testing among the MSM population. This study is divided in two parts. The first one will consist of individual and groups interviews. Then, depending on the items that will rise from the first part of the study, groups interview will take place based on theses items. Finally, a questionnaire build from the collected information will be sent to MSM community in order to obtain quantitative results.
The late recourse to HIV testing, among the population in general way and among MSM population in a more specific way, participates in the dissemination of the HIV epidemic. Actually, there is no cure for HIV infection, but treatments that reduce viral charge to undetectable level exists. When diagnosed and treated earlier, seropositive people will be less communicating the virus because of the reduction of their viral charge. This study aims to uncover the reasons behind the late recourse to HIV testing in MSM population facing a high risk of contamination. The study hypothesis, is that late recourse to HIV testing is probably related to social and economics factors like age, social standing, accessibility to the diagnosis or even to a traditional beliefs or a fear of stigma etc. To shed the light on these factors, the main objectives of the investigator will try to investigate and analyze the psycho-social hindrances and levers through a quantitative and qualitative approach. This plurality of approaches is a part of a methodological triangulation method described by Kalampalikis \& Apostolidis, 2016. People among MSM community having had a late or very late HIV test (as defined by biological parameters :CD4≤200/mm3 or having been diagnosed with AIDS), will be recruited in this study. During the first phase of the study, the eligible population will participate to individual or group interview . This qualitative part of the project will allow the set up of a questionnaire that will be diffused widely to the MSM community to have quantitative results.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Le 190
Paris, France
Hopital Saint-Antoine
Paris, France
Hôpital Pitié-Salpêtrière
Paris, France
Hôpital Bichat Claude-Bernard
Paris, France
Start Date
September 1, 2020
Primary Completion Date
March 1, 2021
Completion Date
March 1, 2022
Last Updated
July 8, 2020
1,190
ESTIMATED participants
Focus group
BEHAVIORAL
Individual interview
BEHAVIORAL
online self questionnaire
BEHAVIORAL
self questionnaire
BEHAVIORAL
Lead Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
NCT04929028
NCT06741631
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06741618